Our Labs
Get to Know our Labs
Chatziioannou Lab
Chatziioannou Lab is developing technology specifically designed for in vivo molecular imaging. The focus of our research is around non-invasive techniques, like positron emission tomography (PET), x-ray micro computed tomography (microCAT) and optical imaging systems.
Clark Lab
The goal of the Clark Lab is to develop new therapies for cancer and autoimmune diseases. The Clark Lab does this by learning from and leveraging positron emission tomography (PET) molecular imaging studies to discover critical pathways in these diseases, by using high-throughput screening efforts to identify new ways to target these pathways, and by further studying these pathways and inhibitors in cell culture and animal models.
Graeber Lab
Graeber Lab is working to understand cancer and disease signaling and metabolism, resistance to molecularly targeted drugs, and immune function from a systems viewpoint. We develop and apply genome-, proteome- and metabolome-wide detection assays, use mathematical and computational approaches to analyze our data, and follow-up our discoveries with targeted validation experiments.
Li Lab
The current focus of the Li lab is to understand the interactions between the microbes and the human host in relation to human health and disease using a systems biology approach. Each individual carries approximately 10 times more bacterial cells than human cells (100 times more genes!).
Murphy Lab
Our lab seeks to discover chemical reactivity that can lead to interdisciplinary solutions for the advancement of human health. Research in our group focuses on developing new methodologies for the preparation of high-affinity imaging probes that are useful for studying biochemical processes using the molecular imaging technique of positron emission tomography (PET).
Tseng Lab
The Tseng Lab is an interdisciplinary research team focused on developing and validating innovative platform technologies for detecting liquid biopsy components, such as circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tumor EVs) from peripheral blood of cancer patients.
Van Dam Lab
The Van Dam Lab focuses on the development of microfluidic technologies and automated systems for radiopharmaceutical synthesis and development, as well as high-throughput synthesis and analysis platforms with applications in cancer research and molecular imaging.
Xu Lab
The Xu Lab specializes in developing and implementing state-of-the-art 𝘪𝘯 𝘷𝘪𝘷𝘰 molecular imaging techniques to non-invasively study a wide range of biological events, disease initiation and progression, cell trafficking, biodistribution of small- and macro- molecules, as well as pharmacodynamics and pharmacokinetics for drug development
Zhu Lab
The Zhu Lab is an interdisciplinary research team focused on developing and validating innovative platform technologies for detecting liquid biopsy components, such as circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tumor EVs) from peripheral blood of cancer patients.